{"component":{"type":17,"accent_color":14707803,"components":[{"type":10,"content":"-# WikiRNG · Roll of 11/21/2026 · by [SEEK](https://wikirng.com/u/SEEK)"},{"type":10,"content":"## [Xeligekimab](https://wikirng.com/roll/RX4MHC)\n*Monoclonal antibody*"},{"type":10,"content":">>> Xeligekimab (development code GR1501; trade name Jinlixi) is a monoclonal antibody that neutralizes interleukin-17A; it is being developed for plaque psoriasis, axial spondyloarthritis, and lupus nephritis."},{"type":14,"divider":true,"spacing":1},{"type":10,"content":"### 🟥 Singularity · 2,335,246 SP\n-# Top 0.092% · ❤️ 10"},{"type":14,"divider":true,"spacing":1},{"type":10,"content":"🟧 💊 **Medicine** · Fabled · +2,248,728 SP\n-# A combination drug, a vaccine, or an experimental drug.\n🟦 🧪 **Gene** · Obscure · +50,772 SP\n-# A gene or protein.\n🟦 🧒 **Orphan** · Obscure · +13,749 SP\n-# Tagged as an orphan (few links point here).\n🟩 🦓 **Zebra** · Notable · +6,935 SP\n-# The title's letters alternate vowel and consonant (7+ letters).\n🟩 🧬 **PubMed** · Notable · +3,084 SP\n-# Links to PubMed.\n🟩 🏜️ **Unlinked** · Notable · +2,526 SP\n-# No article links here.\n-# +15 more badges"},{"type":14,"divider":true,"spacing":1},{"type":1,"components":[{"type":2,"style":5,"label":"View roll","url":"https://wikirng.com/roll/RX4MHC"},{"type":2,"style":5,"label":"Read on Wikipedia","url":"https://en.wikipedia.org/wiki/Xeligekimab"}]},{"type":10,"content":"-# Article text from Wikipedia, CC BY-SA 4.0"}]}}